Wolverine Trading
TNDM icon

Wolverine Trading’s Tandem Diabetes Care TNDM Stock Holding History

Wolverine Trading’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$154K Buy
13,100
+2,400
+22% +$32.5K ﹤0.01% 5047
2025
Q2 		$203K Buy
+10,700
New +$212K ﹤0.01% 3900
2025
Q1 		– Sell
-7,900
Closed -$291K – 5842
2024
Q4 		$291K Buy
7,900
+1,700
+27% +$57.5K ﹤0.01% 4048
2024
Q3 		$263K Sell
6,200
-5,700
-48% -$242K ﹤0.01% 3765
2024
Q2 		$479K Buy
+11,900
New +$496K ﹤0.01% 2891
2023
Q4 		– Sell
-14,300
Closed -$297K – 5222
2023
Q3 		$297K Buy
+14,300
New +$393K ﹤0.01% 3309
2023
Q1 		– Sell
-10,500
Closed -$472K – 4951
2022
Q4 		$472K Sell
10,500
-8,100
-44% -$367K ﹤0.01% 2381
2022
Q3 		$925K Buy
18,600
+14,100
+313% +$773K ﹤0.01% 2041
2022
Q2 		$271K Sell
4,500
-6,800
-60% -$558K ﹤0.01% 3180
2022
Q1 		$1.32M Sell
11,300
-5,800
-34% -$677K ﹤0.01% 2162
2021
Q4 		$2.6M Buy
17,100
+3,800
+29% +$513K ﹤0.01% 1653
2021
Q3 		$1.59M Buy
13,300
+1,900
+17% +$209K ﹤0.01% 2422
2021
Q2 		$1.14M Sell
11,400
-7,000
-38% -$624K ﹤0.01% 2605
2021
Q1 		$1.56M Sell
18,400
-29,300
-61% -$2.72M ﹤0.01% 2208
2020
Q4 		$4.55M Sell
47,700
-3,700
-7% -$381K 0.01% 1125
2020
Q3 		$5.79M Sell
51,400
-2,200
-4% -$231K 0.01% 779
2020
Q2 		$4.71M Sell
53,600
-2,000
-4% -$160K 0.01% 842
2020
Q1 		$3.78M Buy
+55,600
New +$3.9M 0.01% 924
2019
Q4 		– Sell
-73,600
Closed -$4.33M – 5209
2019
Q3 		$4.33M Sell
73,600
-32,300
-31% -$2.06M 0.01% 949
2019
Q2 		$6.83M Buy
105,900
+15,700
+17% +$1.01M 0.02% 715
2019
Q1 		$5.73M Sell
90,200
-4,800
-5% -$252K 0.02% 802
2018
Q4 		$3.54M Sell
95,000
-59,000
-38% -$2.08M 0.01% 1021
2018
Q3 		$6.6M Buy
+154,000
New +$5.38M 0.01% 795

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
FGP
Freestone Grove Partners San Francisco, California $14.2B AUM 24.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wolverine Trading's TNDM Position: Q2 2025 in Review

Wolverine Trading sold out of Tandem Diabetes Care (TNDM) in Q2 2025, closing a stake of 10,973 shares — an estimated $217K sold.

Wolverine Trading first reported a position in TNDM in Q1 2017 and held it in 17 quarters. The position peaked at $4M in Q3 2018. 270 funds tracked by Wall St. Rank hold TNDM as of Q2 2025.

  • Wolverine Trading reported no remaining Tandem Diabetes Care position as of Q2 2025 after selling out during the quarter.
  • Wolverine Trading sold 10,973 Tandem Diabetes Care shares in Q2 2025, an estimated $217K.
  • Wolverine Trading first reported a position in Tandem Diabetes Care in Q1 2017 and held it in 17 quarters.
  • Wolverine Trading's Tandem Diabetes Care position peaked at $4M in Q3 2018.
  • 270 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2025.

Based on Wolverine Trading's 13F filing for Q2 2025, filed 18 Aug 2025.